Ichip platform for culturing unculturable plant-associated microbes

Overview

Plants host diverse microbial communities that enhance growth and stress tolerance, yet the majority of these beneficial microbes remain unculturable using standard laboratory methods. The iChip platform addresses this gap by imposing controlled spatial structures on microbial populations, enabling laboratory cultivation of previously inaccessible strains. This capability opens new opportunities for discovering bacterial species with commercial potential in agriculture and crop science.

Technical specifications

• Spatial partitioning approach: iChip imposes a wide range of spatial partitioning levels on microbial communities, controlling the degree of physical separation between populations
• Diversity gains: Cultured diversity increases by 50% compared with traditional liquid culture and outperforms agar plate methods
• Validated mechanisms: Demonstrated with a 46-strain synthetic community, showing that spatial partitioning promotes growth of populations with negative interactions while suppressing those with positive interactions
• Intermediate partitioning: For mixed communities, intermediate partitioning levels maximize overall diversity
• Microbiome applications: Tested with gut microbiome communities under anaerobic conditions, confirming that different partitioning levels select for different population sets
• Future integration: Planned integration with mathematical modeling, microfluidics, next-generation sequencing, and high-throughput liquid handling for soil and root microbiome applications

Technology readiness level

The iChip platform has been validated using synthetic microbial communities and natural gut microbiome communities, demonstrating consistent diversity gains over conventional methods. The team is now developing a proprietary procedure for environmental sample cultivation, with planned demonstrations on soil and root microbiomes. Ensynble Inc. is actively seeking partnership with crop science organizations to apply iChip toward culturing novel bacterial species with high commercial potential.